The deal reinforces GSK’s leadership in respiratory care and builds upon the company’s expanding COPD portfolio
Test delivers results in just 18 minutes, enabling faster laboratory workflows and patient management during outbreaks
Novelix will provide financial and infrastructural support for the entire technology transfer and scale-up program
Tegoprazan, a novel patented molecule indicated for acid-related gastrointestinal diseases, is launched in India under the brand name PCAB
MKP11093 has shown strong results in preclinical studies with a promising safety and selectivity profile
Argo will receive an upfront payment of $160 million, an option for Profit & Loss split across multiple geographies and potential near-term equity
Dr. Reddy’s becomes the first pharmaceutical company to receive regulatory approval to launch Linaclotide in India under the brand name Colozo
Skyhawk Therapeutics enters into an option agreement to grant Merck KGaA, Darmstadt, Germany, exclusive global rights to drug candidates pursued under the collaboration upon option exercise
Usnoflast has previously also received ‘Orphan Drug Designation (ODD)’ from the USFDA
Findings likely to generate hypotheses about potential new uses of drugs
Subscribe To Our Newsletter & Stay Updated
